Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

October 08, 2021 07:00 ET | Source: Renalytix

Renalytix to Report Fourth Quarter and Full Year Fiscal 2021 Financial Results on October 21

LONDON and SALT LAKE CITY, Oct. 08, 2021 (GLOBE NEWSWIRE) -- Renalytix plc (NASDAQ: RNLX) (LSE: RENX) today announced the Company will release fourth quarter and full year fiscal 2021 financial...
October 07, 2021 07:00 ET | Source: Renalytix AI plc.

Renalytix Launching KidneyIntelX in Veterans Health Administration Hospitals

NEW YORK and SALT LAKE CITY, Oct. 07, 2021 (GLOBE NEWSWIRE) -- Renalytix plc (NASDAQ: RNLX) (LSE: RENX) today announced the expansion of its commercial strategy to address early-stage kidney disease...
September 14, 2021 07:00 ET | Source: Renalytix AI plc.

Mount Sinai Initiates System-wide Scale-Up of Renalytix KidneyIntelX™ Enabled Health Care Model

NEW YORK and SALT LAKE CITY, Sept. 14, 2021 (GLOBE NEWSWIRE) -- Renalytix plc (NASDAQ: RNLX) (LSE: RENX) and the Mount Sinai Health System today announced scaled-up implementation of the...
September 03, 2021 07:00 ET | Source: Renalytix AI plc.

Renalytix to Present at the 2021 Wells Fargo Virtual Healthcare Conference

NEW YORK and SALT LAKE CITY, Sept. 03, 2021 (GLOBE NEWSWIRE) -- Renalytix plc (LSE: RENX) (NASDAQ: RNLX) (“Renalytix” or the “Company”) today announced the company will be presenting at the upcoming...
August 30, 2021 07:00 ET | Source: Renalytix AI plc.

Renalytix Appoints Daniel J. Levangie to its Board of Directors

NEW YORK and SALT LAKE CITY, Aug. 30, 2021 (GLOBE NEWSWIRE) -- Renalytix Plc (NASDAQ: RNLX) (LSE: RENX) today announced the appointment of Daniel J. Levangie to the Company’s board of directors. Mr....
August 26, 2021 07:00 ET | Source: Renalytix AI plc.

Payer Budget Impact Analysis Projects Significant Savings from KidneyIntelX™ Testing at Primary Care Level

NEW YORK and SALT LAKE CITY, Aug. 26, 2021 (GLOBE NEWSWIRE) -- Renalytix Plc (NASDAQ: RNLX) (LSE: RENX) today announced the publication of results from an external chronic kidney disease budget...
July 28, 2021 07:00 ET | Source: Renalytix AI plc.

Renalytix Appoints Ann Berman to its Board of Directors

NEW YORK and SALT LAKE CITY, July 28, 2021 (GLOBE NEWSWIRE) -- Renalytix plc (NASDAQ: RNLX) (LSE: RENX) today announced the appointment of Ann E. Berman to its board of directors. She will chair the...
July 26, 2021 07:00 ET | Source: Renalytix AI plc.

Renalytix to Present at the 41st Annual Canaccord Genuity Global Growth Conference

NEW YORK, July 26, 2021 (GLOBE NEWSWIRE) -- Renalytix plc (LSE: RENX) (NASDAQ: RNLX) (“Renalytix” or the “Company”) today announced the company will be presenting at the upcoming 41st Annual...
July 22, 2021 07:00 ET | Source: Renalytix AI plc.

Renalytix Appoints Joseph Hutson Vice President of Global Quality and Regulatory

NEW YORK and SALT LAKE CITY, July 22, 2021 (GLOBE NEWSWIRE) -- Renalytix Plc (NASDAQ: RNLX) (LSE: RENX) today announced the appointment of Joseph Hutson as its Vice President of Quality and...
June 28, 2021 07:00 ET | Source: Renalytix AI plc.

KidneyIntelX™ Enables Monitoring of SGLT2 Inhibitor Therapy Response and Corresponding Risk Reduction Over Time

NEW YORK, June 28, 2021 (GLOBE NEWSWIRE) -- Renalytix plc (LSE: RENX) (NASDAQ: RNLX) announces new data demonstrating KidneyIntelX™ can be effective at monitoring therapeutic response and...